-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39

Benzinga·07/28/2026 16:51:22
語音播報
UBS analyst Patrick Wood assumes Inspire Medical Systems (NYSE:INSP) with a Sell rating and lowers Price Target of $39.